Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices

Abstract Chronic kidney disease affects millions of people around the globe and many patients rely on hemodialysis (HD) to survive. HD is associated with undesired life-threatening side effects that are linked to membrane biocompatibility and clinical operating conditions. The present study develops...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amira Abdelrasoul, Heloisa Westphalen, Shaghayegh Saadati, Ahmed Shoker
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a2b0c4cdabee47508c9ec1c7a9a8ffca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a2b0c4cdabee47508c9ec1c7a9a8ffca
record_format dspace
spelling oai:doaj.org-article:a2b0c4cdabee47508c9ec1c7a9a8ffca2021-12-05T12:12:33ZHemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices10.1038/s41598-021-01660-12045-2322https://doaj.org/article/a2b0c4cdabee47508c9ec1c7a9a8ffca2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01660-1https://doaj.org/toc/2045-2322Abstract Chronic kidney disease affects millions of people around the globe and many patients rely on hemodialysis (HD) to survive. HD is associated with undesired life-threatening side effects that are linked to membrane biocompatibility and clinical operating conditions. The present study develops a mathematical model to predict the inflammatory biomarkers released in HD patients based on membrane morphology, chemistry, and interaction affinity. Based on the morphological characteristics of two clinical-grade HD membrane modules (CTA and PAES-PVP) commonly used in Canadian hospitals, a molecular docking study, and the release of inflammatory cytokines during HD and in vitro incubation experiments, we develop five sets of equations that describe the concentration of eight biomarkers (serpin/antithrombin-III, properdin, C5a, 1L-1α, 1L-1β, C5b-9, IL6, vWF). The equations developed are functions of membrane properties (pore size, roughness, chemical composition, affinity to fibrinogen, and surface charge) and HD operating conditions (blood flow rate, Qb, and treatment time, t). We expand our model based on available clinical data and increase its range of applicability in terms of flow rate and treatment time. We also modify the original equations to expand their range of applicability in terms of membrane materials, allowing the prediction and validation of the inflammatory response of several clinical and synthesized membrane materials. Our affinity-based model solely relies on theoretical values of molecular docking, which can significantly reduce the experimental load related to the development of more biocompatible materials. Our model predictions agree with experimental clinical data and can guide the development of novel materials and support evidence-based membrane synthesis of HD membranes, reducing the need for trial-and-error approaches.Amira AbdelrasoulHeloisa WestphalenShaghayegh SaadatiAhmed ShokerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Amira Abdelrasoul
Heloisa Westphalen
Shaghayegh Saadati
Ahmed Shoker
Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
description Abstract Chronic kidney disease affects millions of people around the globe and many patients rely on hemodialysis (HD) to survive. HD is associated with undesired life-threatening side effects that are linked to membrane biocompatibility and clinical operating conditions. The present study develops a mathematical model to predict the inflammatory biomarkers released in HD patients based on membrane morphology, chemistry, and interaction affinity. Based on the morphological characteristics of two clinical-grade HD membrane modules (CTA and PAES-PVP) commonly used in Canadian hospitals, a molecular docking study, and the release of inflammatory cytokines during HD and in vitro incubation experiments, we develop five sets of equations that describe the concentration of eight biomarkers (serpin/antithrombin-III, properdin, C5a, 1L-1α, 1L-1β, C5b-9, IL6, vWF). The equations developed are functions of membrane properties (pore size, roughness, chemical composition, affinity to fibrinogen, and surface charge) and HD operating conditions (blood flow rate, Qb, and treatment time, t). We expand our model based on available clinical data and increase its range of applicability in terms of flow rate and treatment time. We also modify the original equations to expand their range of applicability in terms of membrane materials, allowing the prediction and validation of the inflammatory response of several clinical and synthesized membrane materials. Our affinity-based model solely relies on theoretical values of molecular docking, which can significantly reduce the experimental load related to the development of more biocompatible materials. Our model predictions agree with experimental clinical data and can guide the development of novel materials and support evidence-based membrane synthesis of HD membranes, reducing the need for trial-and-error approaches.
format article
author Amira Abdelrasoul
Heloisa Westphalen
Shaghayegh Saadati
Ahmed Shoker
author_facet Amira Abdelrasoul
Heloisa Westphalen
Shaghayegh Saadati
Ahmed Shoker
author_sort Amira Abdelrasoul
title Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
title_short Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
title_full Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
title_fullStr Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
title_full_unstemmed Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
title_sort hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a2b0c4cdabee47508c9ec1c7a9a8ffca
work_keys_str_mv AT amiraabdelrasoul hemodialysisbiocompatibilitymathematicalmodelstopredicttheinflammatorybiomarkersreleasedindialysispatientsbasedonhemodialysismembranecharacteristicsandclinicalpractices
AT heloisawestphalen hemodialysisbiocompatibilitymathematicalmodelstopredicttheinflammatorybiomarkersreleasedindialysispatientsbasedonhemodialysismembranecharacteristicsandclinicalpractices
AT shaghayeghsaadati hemodialysisbiocompatibilitymathematicalmodelstopredicttheinflammatorybiomarkersreleasedindialysispatientsbasedonhemodialysismembranecharacteristicsandclinicalpractices
AT ahmedshoker hemodialysisbiocompatibilitymathematicalmodelstopredicttheinflammatorybiomarkersreleasedindialysispatientsbasedonhemodialysismembranecharacteristicsandclinicalpractices
_version_ 1718372147876855808